Science & Enterprise subscription

Follow us on Twitter

  • Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were high… https://t.co/oLdLmHGz1M
    about 18 hours ago
  • New post on Science and Enterprise: Venture Funds, Mergers in A.I. Up Sharply in 2018 https://t.co/rimak87tjS #Science #Business
    about 18 hours ago
  • Wish it weren't needed, but ... https://t.co/SZAb2GO2vz
    about 3 days ago
  • The Edelman public relations agency released results of a survey earlier this month gauging the public's awareness… https://t.co/XaxxGJOYQl
    about 3 days ago
  • New post on Science and Enterprise: Infographic – Public, Tech Execs Differ on A.I. Use https://t.co/cvVj3IyCR0 #Science #Business
    about 3 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

FDA Approves 25 Precision Meds in 2018

Onpattro

An organization advocating for medicines addressing a person’s unique chemical composition rather than disease symptoms says U.S. regulators approved 25 of those drugs in 2018. . . . → Read More: FDA Approves 25 Precision Meds in 2018

Trial Testing Breath Detection for Cancer

Breath collection device

A clinical trial is recruiting participants to test a technology that analyzes exhaled breath for indicators of specific types of cancer. . . . → Read More: Trial Testing Breath Detection for Cancer

FDA Approves Biomarker-Targeting Cancer Drug

DNA methylation illustration

The Food and Drug Administration yesterday approved a treatment for solid tumor cancers that focuses on specific cancer-causing genetic conditions rather than location of the cancer in the body. . . . → Read More: FDA Approves Biomarker-Targeting Cancer Drug

Gates, Lauder Backing Early Alzheimer’s Biomarker Tests

Brain circuits

A group of well-known philanthropists is backing a new research program to find simple tests that reveal early indicators of Alzheimer’s disease in a person’s molecular make-up. . . . → Read More: Gates, Lauder Backing Early Alzheimer’s Biomarker Tests

Immune Disease Precision Therapy Company Starts Up

An enterprise to discover biomarkers and precise treatments for individuals with immune system disorders is starting up, founded by six researchers in the U.S. and Europe. . . . → Read More: Immune Disease Precision Therapy Company Starts Up

FDA Clears First Blood Test for Concussions

The Food and Drug Administration authorized for marketing in the U.S. a blood test that screens for chemical indicators in the blood for concussions, a form of traumatic brain injury. . . . → Read More: FDA Clears First Blood Test for Concussions

Report: 19 New Precision Medicines Approved in 2017

A report on Food and Drug Administration approvals of new therapies says the agency is accelerating its reviews of treatments designed to address the specific molecular composition of individuals. . . . → Read More: Report: 19 New Precision Medicines Approved in 2017

Microsoft Providing A.I. for Big Data Cancer Research

Seven research teams are receiving grants to study complex problems in cancer immunotherapy with large-scale data sets, and assistance with machine learning and artificial intelligence provided by Microsoft Corp. . . . → Read More: Microsoft Providing A.I. for Big Data Cancer Research

Trial Testing Biomarkers as Brain Injury Diagnostics

A clinical trial is underway in Finland testing the ability to detect traumatic brain injuries with simple blood, urine, and saliva tests. . . . → Read More: Trial Testing Biomarkers as Brain Injury Diagnostics

FDA Approves Precision Solid Tumor Cancer Diagnostics

The Food and Drug Administration approved genomic tests for solid tumor cancers that identify the most promising available therapies matched to the tumor’s genetic mutations. . . . → Read More: FDA Approves Precision Solid Tumor Cancer Diagnostics